Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Radiology

Retrieve available abstracts of 104 articles:
HTML format



Single Articles


    June 2022
  1. JANG JK, Lee ES, Seo JW, Kim YR, et al
    Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study.
    Radiology. 2022 Jun 21:220220. doi: 10.1148/radiol.220220.
    PubMed     Abstract available


  2. GAO RZ, Sun WB, Gao J
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: Is It a Promising Treatment for Giant Liver Hemangioma?
    Radiology. 2022;303:E39.
    PubMed    


  3. RONOT M
    Performance of LI-RADS for the Noninvasive Diagnosis of HCC: Pathology Should Not Be the Only Acceptable Reference.
    Radiology. 2022;303:546-547.
    PubMed    


    May 2022
  4. RAMAN AG, Jones C, Weiss CR
    Machine Learning for Hepatocellular Carcinoma Segmentation at MRI: Radiology In Training.
    Radiology. 2022 May 10:212386. doi: 10.1148/radiol.212386.
    PubMed     Abstract available


    April 2022
  5. BORDE T, Nezami N, Gaupp FL, Savic LJ, et al
    Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI.
    Radiology. 2022 Apr 12:212426. doi: 10.1148/radiol.212426.
    PubMed     Abstract available


  6. WHITE SB
    The Immune Response: A New Frontier in Interventional Oncology.
    Radiology. 2022;303:229-230.
    PubMed    


  7. ATRI M, Jang HJ, Kim TK, Khalili K, et al
    Contrast-enhanced US of the Liver and Kidney: A Problem-solving Modality.
    Radiology. 2022;303:11-25.
    PubMed     Abstract available


  8. KENNEDY P, Marron TU, Taouli B
    Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?
    Radiology. 2022;303:226-228.
    PubMed    


    March 2022
  9. ITO K
    US-derived Fat Fraction Screening of Hepatic Steatosis.
    Radiology. 2022 Mar 29:213052. doi: 10.1148/radiol.213052.
    PubMed    


  10. JUNG J, Han A, Madamba E, Bettencourt R, et al
    Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
    Radiology. 2022 Mar 29:211131. doi: 10.1148/radiol.211131.
    PubMed     Abstract available


  11. LEE JT
    Sarcopenia at Abdominal CT in Patients with Cirrhosis.
    Radiology. 2022 Mar 15:220191. doi: 10.1148/radiol.220191.
    PubMed    


  12. ZAFAR F, Lubert AM, Trout AT, Katz DA, et al
    Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation.
    Radiology. 2022 Mar 15:211037. doi: 10.1148/radiol.211037.
    PubMed     Abstract available


  13. LIU J, Ma J, Yang C, Chen M, et al
    Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.
    Radiology. 2022 Mar 15:211172. doi: 10.1148/radiol.211172.
    PubMed     Abstract available


  14. DHONDT E, Lambert B, Hermie L, Huyck L, et al
    (90)Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial.
    Radiology. 2022 Mar 8:211806. doi: 10.1148/radiol.211806.
    PubMed     Abstract available


  15. VAN DER POL CB, McInnes MDF, Salameh JP, Chernyak V, et al
    Impact of Reference Standard on CT, MRI, and Contrast-enhanced US LI-RADS Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
    Radiology. 2022 Mar 1:212340. doi: 10.1148/radiol.212340.
    PubMed     Abstract available


  16. DUAN L, Zhang BH, Zheng XH
    No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma.
    Radiology. 2022 Mar 1:211994. doi: 10.1148/radiol.211994.
    PubMed    


    February 2022
  17. CHUNG JW
    Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of New Systemic Agents.
    Radiology. 2022 Feb 1:212826. doi: 10.1148/radiol.212826.
    PubMed    


  18. ZHENG K, Zhu X, Fu S, Cao G, et al
    Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.
    Radiology. 2022 Feb 1:211545. doi: 10.1148/radiol.211545.
    PubMed     Abstract available


    January 2022
  19. FERRAIOLI G, Kumar V, Ozturk A, Nam K, et al
    US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.
    Radiology. 2022 Jan 25:210736. doi: 10.1148/radiol.210736.
    PubMed     Abstract available


  20. TISCHFIELD DJ, Gurevich A, Johnson O, Gatmaytan I, et al
    Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat Model.
    Radiology. 2022 Jan 11:211028. doi: 10.1148/radiol.211028.
    PubMed     Abstract available


  21. JENSEN CT, Gupta S, Saleh MM, Liu X, et al
    Reduced-Dose Deep Learning Reconstruction for Abdominal CT of Liver Metastases.
    Radiology. 2022 Jan 11:211838. doi: 10.1148/radiol.211838.
    PubMed     Abstract available


    December 2021
  22. LOCKHART ME
    NASH Diagnosis Made Better but Maybe Not Yet Easier.
    Radiology. 2021;301:635-636.
    PubMed    


  23. SUGIMOTO K, Lee DH, Lee JY, Yu SJ, et al
    Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study.
    Radiology. 2021;301:625-634.
    PubMed     Abstract available


    November 2021
  24. VAN DER POL CB, McInnes MDF, Salameh JP, Levis B, et al
    CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    Radiology. 2021 Nov 16:211244. doi: 10.1148/radiol.2021211244.
    PubMed     Abstract available


  25. MARTI-AGUADO D, Jimenez-Pastor A, Alberich-Bayarri A, Rodriguez-Ortega A, et al
    Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Radiology. 2021 Nov 16:211027. doi: 10.1148/radiol.2021211027.
    PubMed     Abstract available


  26. DING PX, Lee EW
    Spontaneous Portosystemic Shunt with Budd-Chiari Syndrome.
    Radiology. 2021;301:282.
    PubMed     Abstract available


  27. AYOOBI YAZDI N, Mehrabinejad MM, Dashti H, Pourghorban R, et al
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma.
    Radiology. 2021;301:464-471.
    PubMed     Abstract available


    October 2021
  28. PEREZ AA, Noe-Kim V, Lubner MG, Graffy PM, et al
    Deep Learning CT-based Quantitative Visualization Tool for Liver Volume Estimation: Defining Normal and Hepatomegaly.
    Radiology. 2021 Oct 26:210531. doi: 10.1148/radiol.2021210531.
    PubMed     Abstract available


  29. REEDER SB
    Emergence of 3D MR Elastography-based Quantitative Markers for Diffuse Liver Disease.
    Radiology. 2021;301:163-165.
    PubMed    


  30. SOULEN MC, Garcia-Monaco R
    Closing the Gap in Curative Ablation of Liver Cancer.
    Radiology. 2021;301:237-238.
    PubMed    


    September 2021
  31. MORRELL GR
    Detection of Tumor Thrombus in Hepatocellular Carcinoma.
    Radiology. 2021 Sep 28:211984. doi: 10.1148/radiol.2021211984.
    PubMed    


  32. BAE JS, Lee JM, Jeon SK, Yoo J, et al
    LI-RADS Tumor in Vein at CT and Hepatobiliary MRI.
    Radiology. 2021 Sep 28:210215. doi: 10.1148/radiol.2021210215.
    PubMed     Abstract available


  33. YU MM, Tang XL, Jin H, Yang S, et al
    Coronary CT Angiography in Asymptomatic Adults with Hepatic Steatosis.
    Radiology. 2021 Sep 21:210355. doi: 10.1148/radiol.2021210355.
    PubMed     Abstract available


  34. STAREKOVA J, Hernando D, Pickhardt PJ, Reeder SB, et al
    Quantification of Liver Fat Content with CT and MRI: State of the Art.
    Radiology. 2021 Sep 21:204288. doi: 10.1148/radiol.2021204288.
    PubMed     Abstract available


    August 2021
  35. ZHANG T, Zhang G, Deng X, Zeng J, et al
    APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Radiology. 2021 Aug 24:204700. doi: 10.1148/radiol.2021204700.
    PubMed     Abstract available


  36. SHI Y, Qi YF, Lan GY, Wu Q, et al
    Three-dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C.
    Radiology. 2021 Aug 10:202804. doi: 10.1148/radiol.2021202804.
    PubMed     Abstract available


    July 2021
  37. LEE DH, Lee MW, Kim PN, Lee YJ, et al
    Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
    Radiology. 2021 Jul 27:210309. doi: 10.1148/radiol.2021210309.
    PubMed     Abstract available


  38. HE KS, Fernando R, Cabrera T, Valenti D, et al
    Hepatic Hilar Nerve Block for Hepatic Interventions: Anatomy, Technique, and Initial Clinical Experience in Thermal Ablation of Liver Tumors.
    Radiology. 2021 Jul 13:203410. doi: 10.1148/radiol.2021203410.
    PubMed     Abstract available


  39. KRINSKY G, Shanbhogue K
    Proliferative versus Nonproliferative Hepatocellular Carcinoma: Clinical and Imaging Implications.
    Radiology. 2021 Jul 6:211316. doi: 10.1148/radiol.2021211316.
    PubMed    


  40. KANG HJ, Kim H, Lee DH, Hur BY, et al
    Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Radiology. 2021 Jul 6:204352. doi: 10.1148/radiol.2021204352.
    PubMed     Abstract available


    June 2021
  41. JIANG H, Chen HC, Lafata KJ, Bashir MR, et al
    Week 4 Liver Fat Reduction on MRI as an Early Predictor of Treatment Response in Participants with Nonalcoholic Steatohepatitis.
    Radiology. 2021 Jun 1:204325. doi: 10.1148/radiol.2021204325.
    PubMed     Abstract available


  42. DU J, Bydder GM
    Brain Atrophy Is a Better Biomarker than Susceptibility for Evaluating Clinical Severity in Wilson Disease.
    Radiology. 2021;299:673-674.
    PubMed    


    May 2021
  43. BAI XM, Cui M, Yang W, Wang H, et al
    The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Radiology. 2021 May 18:200153. doi: 10.1148/radiol.2021200153.
    PubMed     Abstract available


  44. YOON JH, Kim H
    CT Characterization of Aggressive Macrotrabecular-Massive Hepatocellular Carcinoma: A Step Forward to Personalized Medicine.
    Radiology. 2021 May 11:210379. doi: 10.1148/radiol.2021210379.
    PubMed    


  45. FENG Z, Li H, Zhao H, Jiang Y, et al
    Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
    Radiology. 2021 May 11:203614. doi: 10.1148/radiol.2021203614.
    PubMed     Abstract available


  46. MEIJERINK MR, Ruarus AH, Vroomen LGPH, Puijk RS, et al
    Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Radiology. 2021;299:470-480.
    PubMed     Abstract available


    April 2021
  47. PAISANT A, Gillard M, Oberti F, Roux M, et al
    Validation of a Diagnostic Algorithm for Hepatocellular Carcinoma at Gadoxetic Acid-enhanced MRI.
    Radiology. 2021 Apr 27:204529. doi: 10.1148/radiol.2021204529.
    PubMed     Abstract available


  48. LV J, Xu Y, Xu L, Nie L, et al
    Quantitative Functional Evaluation of Liver Fibrosis in Mice with Dynamic Contrast-enhanced Photoacoustic Imaging.
    Radiology. 2021 Apr 27:204134. doi: 10.1148/radiol.2021204134.
    PubMed     Abstract available


  49. LUZ JHM, Veloso Gomes F, Costa NV, Vasco I, et al
    BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils.
    Radiology. 2021 Apr 6:204055. doi: 10.1148/radiol.2021204055.
    PubMed     Abstract available


    March 2021
  50. O'SHEA A, Pierce TT
    US Elastography in Hepatic Fibrosis-Radiology In Training.
    Radiology. 2021 Mar 23:203893. doi: 10.1148/radiol.2021203893.
    PubMed     Abstract available


  51. DUSEK P, Lescinskij A, Ruzicka F, Acosta-Cabronero J, et al
    Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
    Radiology. 2021 Mar 23:202846. doi: 10.1148/radiol.2021202846.
    PubMed     Abstract available


  52. BAE JS, Lee JM, Yoon JH, Kang HJ, et al
    Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
    Radiology. 2021 Mar 2:203537. doi: 10.1148/radiol.2021203537.
    PubMed     Abstract available


  53. BASHIR MR, Mendiratta-Lala M
    CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.
    Radiology. 2021 Mar 2:210049. doi: 10.1148/radiol.2021210049.
    PubMed    


    February 2021
  54. PALTIEL HJ
    LI-RADS Version 2018 Is of Limited Use in the Diagnosis of Hepatocellular Carcinoma in Children.
    Radiology. 2021 Feb 23:204480. doi: 10.1148/radiol.2021204480.
    PubMed    


  55. KHANNA G, Chavhan GB, Schooler GR, Fraum TJ, et al
    Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma.
    Radiology. 2021 Feb 23:203559. doi: 10.1148/radiol.2021203559.
    PubMed     Abstract available


  56. NARDELLI S, Riggio O, Turco L, Gioia S, et al
    Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis.
    Radiology. 2021 Feb 2:203051. doi: 10.1148/radiol.2021203051.
    PubMed     Abstract available


  57. REEDER SB
    Portosystemic Shunts: Should We Pay Closer Attention with Cross-Sectional Imaging?
    Radiology. 2021 Feb 2:204282. doi: 10.1148/radiol.2021204282.
    PubMed    


    January 2021
  58. KARMEGARAJ B
    Normal Fetal Umbilical, Portal, and Hepatic Venous System: Four-dimensional STIC Rendering.
    Radiology. 2021 Jan 26:203300. doi: 10.1148/radiol.2021203300.
    PubMed     Abstract available


  59. MADOFF DC, Cornman-Homonoff J, Fortune BE, Gaba RC, et al
    Management of Refractory Ascites Due to Portal Hypertension: Current Status.
    Radiology. 2021 Jan 26:201960. doi: 10.1148/radiol.2021201960.
    PubMed     Abstract available


  60. CHEN S, Peng Z, Zhang Y, Chen M, et al
    Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?
    Radiology. 2021 Jan 19:202289. doi: 10.1148/radiol.2021202289.
    PubMed     Abstract available


  61. HU HH, Yokoo T, Bashir MR, Sirlin CB, et al
    Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study.
    Radiology. 2021 Jan 19:202912. doi: 10.1148/radiol.2021202912.
    PubMed     Abstract available


  62. CHANDARANA H, Shanbhogue K
    Noninvasive Staging of Liver Fibrosis with Dual-Energy CT: Close but No Cigar.
    Radiology. 2021 Jan 5:204315. doi: 10.1148/radiol.2021204315.
    PubMed    


  63. MARRI UK, Das P, Shalimar, Kalaivani M, et al
    Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings.
    Radiology. 2021 Jan 5:202232. doi: 10.1148/radiol.2021202232.
    PubMed     Abstract available


  64. KIESSLING F
    US Microbubbles as Smart Sensors of Portal Venous Pressure.
    Radiology. 2021;298:112-113.
    PubMed    


  65. HAN K, Kim JH, Yang SG, Park SH, et al
    A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Radiology. 2021;298:212-218.
    PubMed     Abstract available


  66. KANG TW, Jeong WK, Kim YY, Min JH, et al
    Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia.
    Radiology. 2021;298:82-90.
    PubMed     Abstract available


    December 2020
  67. EISENBREY JR, Forsberg F, Wessner CE, Delaney LJ, et al
    US-triggered Microbubble Destruction for Augmenting Hepatocellular Carcinoma Response to Transarterial Radioembolization: A Randomized Pilot Clinical Trial.
    Radiology. 2020 Dec 15:202321. doi: 10.1148/radiol.2020202321.
    PubMed     Abstract available


    November 2020
  68. ROSTAMBEIGI N, Farsad K, Young S, Shrestha P, et al
    Lower-Extremity Edema Is Common after Transjugular Intrahepatic Portosystemic Shunt Creation and Is Associated with Lower Survival: A Two-Institution Study.
    Radiology. 2020 Nov 17:201690. doi: 10.1148/radiol.2020201690.
    PubMed     Abstract available


  69. GUPTA I, Eisenbrey JR, Machado P, Stanczak M, et al
    Diagnosing Portal Hypertension with Noninvasive Subharmonic Pressure Estimates from a US Contrast Agent.
    Radiology. 2020 Nov 17:202677. doi: 10.1148/radiol.2020202677.
    PubMed     Abstract available


  70. FRULIO N, Balabaud C, Trillaud H, Bioulac-Sage P, et al
    Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
    Radiology. 2020 Nov 10:203244. doi: 10.1148/radiol.2020203244.
    PubMed    


  71. SOULEN MC, Sofocleous CT
    Achieving Curative Ablation Outcomes: It Is All about the Imaging.
    Radiology. 2020 Nov 10:203930. doi: 10.1148/radiol.2020203930.
    PubMed    


    October 2020
  72. FETZER DT
    Recent Advances in US Vascular Imaging: Highlighting an Important Use Case.
    Radiology. 2020 Oct 27:203830. doi: 10.1148/radiol.2020203830.
    PubMed    


  73. BASHIR MR
    Patient Triage for Resection of Metastatic Colorectal Cancer to the Liver: Can We Do Better Using MRI?
    Radiology. 2020 Oct 6:203631. doi: 10.1148/radiol.2020203631.
    PubMed    


  74. NAKAI Y, Gonoi W, Kurokawa R, Nishioka Y, et al
    MRI Findings of Liver Parenchyma Peripheral to Colorectal Liver Metastasis: A Potential Predictor of Long-term Prognosis.
    Radiology. 2020 Oct 6:202367. doi: 10.1148/radiol.2020202367.
    PubMed     Abstract available


  75. DAVARPANAH AH, Eberhardt LW
    Case 282: Fishbone Pylephlebitis.
    Radiology. 2020;297:239-243.
    PubMed     Abstract available


  76. DE ROOS A, Lamb HJ
    Exploring the Interaction between Liver and Heart Disease.
    Radiology. 2020;297:62-63.
    PubMed    


  77. WEISS CR, Nezami N
    One Step Closer to Precision Medicine for Transarterial Therapy of HCC.
    Radiology. 2020;297:235-236.
    PubMed    


    September 2020
  78. TANG A
    Using MRI to Assess Microvascular Invasion in Hepatocellular Carcinoma.
    Radiology. 2020 Sep 29:203376. doi: 10.1148/radiol.2020203376.
    PubMed    


  79. WANG F, Numata K, Ruan L
    Accurate Assessment of Vascularity of Focal Hepatic Lesions in Arterial Phase Imaging.
    Radiology. 2020 Sep 29:202780. doi: 10.1148/radiol.2020202780.
    PubMed    


  80. MIN JH, Lee MW, Park HS, Lee DH, et al
    Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
    Radiology. 2020 Sep 29:201940. doi: 10.1148/radiol.2020201940.
    PubMed     Abstract available


  81. DO RK, Mendiratta-Lala M
    Moving Away from Uncertainty: A Potential Role for Ancillary Features in LI-RADS Treatment Response.
    Radiology. 2020;296:562-563.
    PubMed    


  82. SOFOCLEOUS CT, Vasiniotis Kamarinos N
    Tumor Radiation-absorbed Dose: The Missing Link in Radioembolization.
    Radiology. 2020;296:685-686.
    PubMed    


    August 2020
  83. KANG HJ, Lee JM, Yoon JH, Lee K, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Radiology. 2020 Aug 25:209017. doi: 10.1148/radiol.2020209017.
    PubMed    


  84. ISAAK A, Praktiknjo M, Jansen C, Faron A, et al
    Myocardial Fibrosis and Inflammation in Liver Cirrhosis: MRI Study of the Liver-Heart Axis.
    Radiology. 2020 Aug 18:201057. doi: 10.1148/radiol.2020201057.
    PubMed     Abstract available


  85. ZIV E, Zhang Y, Kelly L, Nikolovski I, et al
    NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation.
    Radiology. 2020 Aug 11:200201. doi: 10.1148/radiol.2020200201.
    PubMed     Abstract available


  86. KANG HJ, Lee JM, Yoon JH, Lee K, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Radiology. 2020 Aug 4:200115. doi: 10.1148/radiol.2020200115.
    PubMed     Abstract available


  87. KIM TK, Jang HJ
    Emerging Evidence of the Utility of Perfluorobutane-enhanced US as a Diagnostic Test for Hepatocellular Carcinoma.
    Radiology. 2020 Aug 4:202763. doi: 10.1148/radiol.2020202763.
    PubMed    


    July 2020
  88. PARK S, Joo I, Lee DH, Bae JS, et al
    Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.
    Radiology. 2020 Jul 21:192797. doi: 10.1148/radiol.2020192797.
    PubMed     Abstract available


  89. SAVIC LJ, Doemel LA, Schobert IT, Montgomery RR, et al
    Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?
    Radiology. 2020 Jul 7:200373. doi: 10.1148/radiol.2020200373.
    PubMed     Abstract available


    June 2020
  90. SCHOOLER GR, Squires JH, Alazraki A, Chavhan GB, et al
    Pediatric Hepatoblastoma, Hepatocellular Carcinoma, and Other Hepatic Neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group.
    Radiology. 2020 Jun 30:200751. doi: 10.1148/radiol.2020200751.
    PubMed     Abstract available


  91. HERMANN AL, Dieudonne A, Ronot M, Sanchez M, et al
    Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with (90)Y in the SARAH Study.
    Radiology. 2020 Jun 30:191606. doi: 10.1148/radiol.2020191606.
    PubMed     Abstract available


  92. SUGIMOTO K, Moriyasu F, Oshiro H, Takeuchi H, et al
    The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis.
    Radiology. 2020 Jun 23:192665. doi: 10.1148/radiol.2020192665.
    PubMed     Abstract available


  93. BARR RG, Wilson SR, Rubens D, Garcia-Tsao G, et al
    Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement.
    Radiology. 2020 Jun 9:192437. doi: 10.1148/radiol.2020192437.
    PubMed     Abstract available


  94. MOTOSUGI U
    Treat or Wait? Hepatobiliary Phase Hypointense Nodule without Arterial Phase Hyperenhancement.
    Radiology. 2020 Jun 2:201726. doi: 10.1148/radiol.2020201726.
    PubMed    


  95. JOO I, Kim SY, Kang TW, Kim YK, et al
    Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
    Radiology. 2020 Jun 2:192275. doi: 10.1148/radiol.2020192275.
    PubMed     Abstract available


    May 2020
  96. GIORGIO A, De Luca M, Gatti P, Matteucci P, et al
    CEUS LI-RADS Categories to Distinguish Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma Malignancies.
    Radiology. 2020 May 12:200623. doi: 10.1148/radiol.2020200623.
    PubMed    


  97. LOCKHART ME, Smith AD
    Fatty Liver Disease: Artificial Intelligence Takes on the Challenge.
    Radiology. 2020;295:351-352.
    PubMed    


    April 2020
  98. ZHOU IY, Clavijo Jordan V, Rotile NJ, Akam E, et al
    Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis.
    Radiology. 2020 Apr 28:192118. doi: 10.1148/radiol.2020192118.
    PubMed     Abstract available


    March 2020
  99. MULE S, Galletto Pregliasco A, Tenenhaus A, Kharrat R, et al
    Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
    Radiology. 2020 Mar 31:192230. doi: 10.1148/radiol.2020192230.
    PubMed     Abstract available


    February 2020
  100. HAN A, Byra M, Heba E, Andre MP, et al
    Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.
    Radiology. 2020 Feb 25:191160. doi: 10.1148/radiol.2020191160.
    PubMed     Abstract available


  101. KONO Y, Sirlin CB, Fetzer DT, Kim TK, et al
    Time to Clarify Common Misconceptions about the Liver Imaging Reporting and Data System for Contrast-enhanced US.
    Radiology. 2020 Feb 18:192557. doi: 10.1148/radiol.2020192557.
    PubMed    


  102. KROMREY ML, Le Bihan D, Ichikawa S, Motosugi U, et al
    Diffusion-weighted MRI-based Virtual Elastography for the Assessment of Liver Fibrosis.
    Radiology. 2020 Feb 11:191498. doi: 10.1148/radiol.2020191498.
    PubMed     Abstract available


  103. DO RK, Mendiratta-Lala M
    LI-RADS Version 2018 Treatment Response Algorithm: The Evidence Is Accumulating.
    Radiology. 2020;294:327-328.
    PubMed    


    November 2019
  104. BASTATI N, Beer L, Mandorfer M, Poetter-Lang S, et al
    Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
    Radiology. 2019 Nov 19:190734. doi: 10.1148/radiol.2019190734.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: